BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE and DRUG INEFFECTIVE

Overview

DRUG INEFFECTIVE is the #2 most commonly reported adverse reaction for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, manufactured by Padagis Israel Pharmaceuticals Ltd. There are 10 FDA adverse event reports linking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE to DRUG INEFFECTIVE. This represents approximately 3.9% of all 256 adverse event reports for this drug.

Patients taking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG INEFFECTIVE is moderately reported among BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.

Other Side Effects of BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE

In addition to drug ineffective, the following adverse reactions have been reported for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE:

• DRUG HYPERSENSITIVITY — 10 reports
• PRURITUS — 7 reports
• CONSTIPATION — 6 reports
• OFF LABEL USE — 6 reports
• RASH — 6 reports
• DYSPNOEA — 5 reports
• FATIGUE — 5 reports
• MALAISE — 5 reports
• NAUSEA — 5 reports
• PAIN — 5 reports

Other Drugs Associated with DRUG INEFFECTIVE

The following drugs have also been linked to drug ineffective in FDA adverse event reports:

Does BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE cause DRUG INEFFECTIVE?

DRUG INEFFECTIVE has been reported as an adverse event in 10 FDA reports for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG INEFFECTIVE with BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE?

DRUG INEFFECTIVE accounts for approximately 3.9% of all adverse event reports for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, making it one of the most commonly reported side effect.

What should I do if I experience DRUG INEFFECTIVE while taking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE?

If you experience drug ineffective while taking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages